Compare SRTA & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRTA | BIOA |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.2M | 443.9M |
| IPO Year | N/A | 2024 |
| Metric | SRTA | BIOA |
|---|---|---|
| Price | $5.65 | $18.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.63 | ★ $13.50 |
| AVG Volume (30 Days) | 873.4K | ★ 897.3K |
| Earning Date | 02-15-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $268,618,000.00 | $5,917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24.64 | N/A |
| P/E Ratio | $12.10 | ★ N/A |
| Revenue Growth | ★ 70.11 | N/A |
| 52 Week Low | $2.35 | $2.88 |
| 52 Week High | $6.02 | $24.00 |
| Indicator | SRTA | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 59.80 |
| Support Level | N/A | $19.06 |
| Resistance Level | N/A | $21.53 |
| Average True Range (ATR) | 0.00 | 2.22 |
| MACD | 0.00 | 0.24 |
| Stochastic Oscillator | 0.00 | 57.64 |
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.